Cholera

被引:431
作者
Harris, Jason B. [1 ,2 ]
LaRocque, Regina C. [1 ,3 ]
Qadri, Firdausi [5 ]
Ryan, Edward T. [1 ,3 ,6 ]
Calderwood, Stephen B. [1 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA
[5] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh
[6] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;
关键词
ENTEROTOXIGENIC ESCHERICHIA-COLI; SINGLE-DOSE CIPROFLOXACIN; LATEX AGGLUTINATION ASSAY; ORAL REHYDRATION SOLUTION; VACCINE CVD 103-HGR; VIBRIO-CHOLERAE; WHOLE-CELL; FIELD TRIAL; PROTECTIVE EFFICACY; IMMUNE-RESPONSES;
D O I
10.1016/S0140-6736(12)60436-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120 000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0.2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.
引用
收藏
页码:2466 / 2476
页数:11
相关论文
共 148 条
[61]   Hyperinfectivity:: A critical element in the ability of V.cholerae to cause epidemics? [J].
Hartley, DM ;
Morris, JG ;
Smith, DL .
PLOS MEDICINE, 2006, 3 (01) :63-69
[62]   A NOVEL KIT FOR RAPID DETECTION OF VIBRIO-CHOLERAE 01 [J].
HASAN, JAK ;
HUQ, A ;
TAMPLIN, ML ;
SIEBELING, RJ ;
COLWELL, RR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (01) :249-252
[63]   DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae [J].
Heidelberg, JF ;
Eisen, JA ;
Nelson, WC ;
Clayton, RA ;
Gwinn, ML ;
Dodson, RJ ;
Haft, DH ;
Hickey, EK ;
Peterson, JD ;
Umayam, L ;
Gill, SR ;
Nelson, KE ;
Read, TD ;
Tettelin, H ;
Richardson, D ;
Ermolaeva, MD ;
Vamathevan, J ;
Bass, S ;
Qin, HY ;
Dragoi, I ;
Sellers, P ;
McDonald, L ;
Utterback, T ;
Fleishmann, RD ;
Nierman, WC ;
White, O ;
Salzberg, SL ;
Smith, HO ;
Colwell, RR ;
Mekalanos, JJ ;
Venter, JC ;
Fraser, CM .
NATURE, 2000, 406 (6795) :477-483
[64]   Susceptibility to Fluoroquinolones of Vibrio cholerae O1 Isolated From Diarrheal Patients in Zimbabwe [J].
Islam, M. Sirajul ;
Midzi, Stanley M. ;
Charimari, Lincoln ;
Cravioto, Alejandro ;
Endtz, Hubert P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21) :2321-2322
[65]   Five complementary interventions to slow cholera: Haiti [J].
Ivers, Louise C. ;
Farmer, Paul ;
Almazor, Charles Patrick ;
Leandre, Fernet .
LANCET, 2010, 376 (9758) :2048-2051
[66]   Modeling the role of bacteriophage in the control of cholera outbreaks [J].
Jensen, MA ;
Faruque, SM ;
Mekalanos, JJ ;
Levin, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) :4652-4657
[67]   Cost-Effectiveness of New-Generation Oral Cholera Vaccines: A Multisite Analysis [J].
Jeuland, Marc ;
Cook, Joseph ;
Poulos, Christine ;
Clemens, John ;
Whittington, Dale .
VALUE IN HEALTH, 2009, 12 (06) :899-908
[68]   Warming Oceans, Phytoplankton, and River Discharge: Implications for Cholera Outbreaks [J].
Jutla, Antarpreet S. ;
Akanda, Ali S. ;
Griffiths, Jeffrey K. ;
Colwell, Rita ;
Islam, Shafiqul .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (02) :303-308
[69]   Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial [J].
Kanungo, Suman ;
Paisley, Allison ;
Lopez, Anna Lena ;
Bhattacharya, Mihir ;
Manna, Byomkesh ;
Kim, Deok Ryun ;
Han, Seung Hyun ;
Attridge, Stephen ;
Carbis, Rodney ;
Rao, Raman ;
Holmgren, Jan ;
Clemens, John D. ;
Sur, Dipika .
VACCINE, 2009, 27 (49) :6887-6893
[70]   A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria [J].
Karaolis, DKR ;
Somara, S ;
Maneval, DR ;
Johnson, JA ;
Kaper, JB .
NATURE, 1999, 399 (6734) :375-379